The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity
吉非替尼和 RAD001 的组合可抑制 HER2 过度表达乳腺癌细胞和肿瘤的生长，无论曲妥珠单抗敏感性如何
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/1471-2407-11-420
Wieslawa H Dragowska, Sherry A Weppler, Mohammed A Qadir, Ling Yan Wong, Yannick Franssen, Jennifer H E Baker, Anita I Kapanen, Guido J J Kierkels, Dana Masin, Andrew I Minchinton, Karen A Gelmon, Marcel B Bally
